Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 February 2005, Vol. 105, No. 4, pp. 1823-1827.
Prepublished online as a Blood First Edition Paper on October 21, 2004; DOI 10.1182/blood-2004-07-2832.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-07-2832v1
105/4/1823    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mommaas, B.
Right arrow Articles by Goulmy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mommaas, B.
Right arrow Articles by Goulmy, E.
Related Collections
Right arrow Transplantation
Right arrow Immunobiology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TRANSPLANTATION

Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1

Bregje Mommaas, Janine A. Stegehuis-Kamp, Astrid G. van Halteren, Michel Kester, Jürgen Enczmann, Peter Wernet, Gesine Kögler, Tuna Mutis, Anneke Brand, and Els Goulmy

From the Department of Immunohematology and Blood Transfusion; the Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands; the Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Dusseldorf, Germany; and the Sanquin Blood Bank, Leiden, The Netherlands.

Umbilical cord blood transplantation is applied as treatment for mainly pediatric patients with hematologic malignancies. The clinical results show a relatively low incidence of graft-versus-host disease and leukemia relapse. Since maternal cells traffic into the fetus during pregnancy, we questioned whether cord blood has the potential to generate cytotoxic T cells specific for the hematopoietic minor histocompatibility (H) antigen HA-1 that would support the graft-versus-leukemia effect. Here, we demonstrate the feasibility of ex vivo generation of minor H antigen HA-1-specific T cells from cord blood cells. Moreover, we observed pre-existing HA-1-specific T cells in cord blood samples. Both the circulating and the ex vivo-generated HA-1-specific T cells show specific and hematopoietic restricted lysis of human leukocyte antigen-A2pos/HA-1pos (HLA-A2pos/HA-1pos) target cells, including leukemic cells. The cord blood-derived HA-1-specific cytotoxic T cells are from child origin. Thus, the so-called naive cord blood can comprise cytotoxic T cells directed at the maternal minor H antigen HA-1. The apparent immunization status of cord blood may well contribute to the in vivo graft-versus-leukemia activity after transplantation. Moreover, since the fetus cannot be primed against Y chromosome-encoded minor H antigens, cord blood is an attractive stem cell source for male patients. (Blood. 2005;105:1823-1827)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
A. L. Feitsma, J. Worthington, A. H. M. van der Helm-van Mil, D. Plant, W. Thomson, J. Ursum, D. van Schaardenburg, I. E. van der Horst-Bruinsma, J. J. van Rood, T. W. J. Huizinga, et al.
Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development
PNAS, December 11, 2007; 104(50): 19966 - 19970.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Mullally and J. Ritz
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation
Blood, February 15, 2007; 109(4): 1355 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Schilbach, G. Kerst, S. Walter, M. Eyrich, D. Wernet, R. Handgretinger, W. Xie, H.-G. Rammensee, I. Muller, H.-J. Buhring, et al.
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction
Blood, July 1, 2005; 106(1): 144 - 149.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
W. Tse and M. J. Laughlin
Umbilical Cord Blood Transplantation: A New Alternative Option
Hematology, January 1, 2005; 2005(1): 377 - 383.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020